Cargando…
Considerations for a Reliable In Vitro Model of Chemotherapy-Induced Peripheral Neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN) is widely recognized as a potentially severe toxicity that often leads to dose reduction or discontinuation of cancer treatment. Symptoms may persist despite discontinuation of chemotherapy and quality of life can be severely compromised. The clinica...
Autores principales: | Eldridge, Sandy, Scuteri, Arianna, Jones, Eugenia M. C., Cavaletti, Guido, Guo, Liang, Glaze, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620674/ https://www.ncbi.nlm.nih.gov/pubmed/34822690 http://dx.doi.org/10.3390/toxics9110300 |
Ejemplares similares
-
Axonal Transport Impairment in Chemotherapy-Induced Peripheral Neuropathy
por: Nicolini, Gabriella, et al.
Publicado: (2015) -
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy
por: Fumagalli, Giulia, et al.
Publicado: (2021) -
Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy
por: Cavaletti, Guido, et al.
Publicado: (2020) -
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice
por: Renn, Cynthia L, et al.
Publicado: (2011) -
Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy
por: Cavaletti, Guido, et al.
Publicado: (2023)